The global Ultomiris Drug Market is witnessing robust growth, driven by the increasing prevalence of rare complement-mediated diseases, expanding regulatory approvals, and growing adoption of long-acting biologic therapies. The market is projected to grow from USD 5.2 billion in 2025 to USD 14.9 billion by 2033, registering a CAGR of 14.4% during the forecast period....
